What is HOB Biotech Group Corp.,Ltd's (688656.SS) StockRank?

MoatMap's StockRank for HOB Biotech Group Corp.,Ltd (688656.SS) is 6/100, with a Strong Sell signal. This is a composite score combining Quality (59), Value (8), and Momentum (19) factor ranks across MoatMap's 20,000+ stock universe.

Does HOB Biotech Group Corp.,Ltd have an economic moat?

HOB Biotech Group Corp.,Ltd (688656.SS) has a Quality factor score of 59/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is HOB Biotech Group Corp.,Ltd a buy, hold, or sell?

MoatMap's current signal for HOB Biotech Group Corp.,Ltd (688656.SS) is Strong Sell, based on a StockRank of 6/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is HOB Biotech Group Corp.,Ltd in?

HOB Biotech Group Corp.,Ltd (688656.SS) operates in the Healthcare sector, specifically the Medical Devices industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

688656.SS

STRONG SELLREMOVE

HOB Biotech Group Corp.,Ltd · Healthcare · China · $1.0B · Avg Vol: $8M/d

StockRank

P/E (TTM)

284.4x

ROE

2.6%

D/E

0.0x

Dividend %

0.2%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

HOB Biotech Group specializes in allergy and autoimmune in vitro diagnostic reagents. It is a small-scale player facing intense domestic competition and centralized government procurement price cuts in China, preventing it from achieving high-conviction status.

COMPANY DESCRIPTION

HOB Biotech Group Corp., Ltd. develops, manufactures, and markets in vitro diagnostic (IVD) reagents and instruments, specializing in allergy and autoimmune disease testing. The company is a market leader in China's allergy diagnostic sector, leveraging a comprehensive portfolio of proprietary test kits. Its vertically integrated production and established hospital distribution network provide a robust competitive moat.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR
Revenue	47M	58M	59M	59M	7.5%
EPS	0.10	0.11	0.09	0.05	-17.5%
Shares	63M	63M	63M	63M	+0.7%
Debt	10M	8M	17M	7M	-10.2%
Equity	115M	120M	120M	121M	1.7%
Op CF	9M	15M	15M	11M	7.8%
Inv CF	-51M	-6M	-23M	-7M	—
Fin CF	-2M	-8M	2M	-13M	—

PRICE (1M)-26.6%

SMA 50SMA 200

$15.62

RSI (14)

42.4

52W High

$32.01

From 52W High

0.5%

SCORE BREAKDOWN

Quality

ROIC

3.3%51.4

ROE

2.6%49.6

GP/Assets

25.1%56.8

Op. Margin

0.3%45.5

FCF/Assets

2.8%60.8

Piotroski

—83.4

Int. Cover

12.6x68.0

D/E Ratio

0.04x76.2

Current Ratio

2.75x49.8

Value

P/E (TTM)

284.4x3.3

EV/EBITDA

72.7x4.4

P/FCF

1853.4x4.6

P/B

7.3x15.8

P/S

15.4x19.9

Div Yield

0.2%6.1

Momentum

52W High %

49%22.3

RS 6M

-58%19.2

SMA 50/200

0.84x20.1

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

-89%2.3

FUNDAMENTALS

Market Cap

$1.0B

P/E (Forward)

—

Gross Margin

58.2%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 688656.SS are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
688656.SS	HOB Biotech Group Corp.,Ltd(you)	$1.0B	6	STRONG SELL
301602.SZ	Shantou Institute of Ultrasonic Instrument Co., Ltd.	$1.0B	15	STRONG SELL
688085.SS	Shanghai Sanyou Medical Co., Ltd	$755M	17	STRONG SELL
688626.SS	Xiangyu Medical Co.,Ltd	$1.2B	20	SELL
688212.SS	Shanghai Aohua Photoelectricity Endoscope Co., Ltd.	$603M	16	STRONG SELL
300869.SZ	Contec Medical Systems Co.,Ltd	$681M	21	SELL
688575.SS	Shenzhen YHLO Biotech Co., Ltd.	$870M	26	SELL
1609.HK	Star Sports Medicine Co., Ltd.	$1.4B	26	SELL
300633.SZ	SonoScape Medical Corp.	$1.3B	28	SELL
0853.HK	MicroPort Scientific Corporation	$1.8B	22	SELL

Peer medians: ROE 4.8% · P/E 27.6x · Gross margin 53.0%

HOB Biotech Group Corp.,Ltd (688656.SS) — Stock Score Summary

HOB Biotech Group Corp.,Ltd (688656.SS) has a MoatMap StockRank of 6/100 based on Quality (59/100), Value (8/100), and Momentum (19/100) factor scores. The current signal is STRONG SELL. HOB Biotech Group specializes in allergy and autoimmune in vitro diagnostic reagents. It is a small-scale player facing intense domestic competition and centralized government procurement price cuts in China, preventing it from achieving high-conviction status.

Key Financial Metrics

Price	$15.62
Market Cap	$1.0B
P/E (TTM)	284.38
Price/Book	7.33
Return on Equity	2.6%
Return on Invested Capital	3.3%
Debt/Equity	3.88
Gross Margin	58.2%
Operating Margin	0.3%
Revenue Growth	1.6%
Dividend Yield	0.2%
Free Cash Flow	$565K

HOB Biotech Group Corp.,Ltd operates in the Medical Devices industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is HOB Biotech Group Corp.,Ltd’s (688656.SS) StockRank?: MoatMap’s StockRank for HOB Biotech Group Corp.,Ltd (688656.SS) is 6/100, with a Strong Sell signal. It is a composite of Quality (59), Value (8), and Momentum (19) factor ranks across MoatMap’s 20,000+ stock universe.
Does HOB Biotech Group Corp.,Ltd have an economic moat?: HOB Biotech Group Corp.,Ltd (688656.SS) has a Quality factor score of 59/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is HOB Biotech Group Corp.,Ltd a buy, hold, or sell?: MoatMap’s current signal for HOB Biotech Group Corp.,Ltd (688656.SS) is Strong Sell, based on a StockRank of 6/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is HOB Biotech Group Corp.,Ltd in?: HOB Biotech Group Corp.,Ltd (688656.SS) operates in the Healthcare sector, specifically the Medical Devices industry (China).